Several weight-loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market — which is projected to hit $105 billion by 2030, according to Morgan Stanley (MS) analysts.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Hims & Hers, Zealand, and Roche — why these weight loss drug stocks are down today )
Also on site :
- From the Global South to the stars: A new space race
- China's property sector has been in an extended slump. Shrinking population is making it worse
- A lesson for the West? Japan was better prepared than most for China’s rare-earth mineral squeeze